Gaetano Rocco

Thoracic Surgery

530 E 74th St
New York, NY 10021

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 350 publications

Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 16, 2026

The 2026 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of primary chest wall malignancies.

The 2026 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of primary chest wall malignancies.

Journal: The Journal of thoracic and cardiovascular surgery

Published: December 10, 2025

A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases.

A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases.

Journal: Frontiers in bioengineering and biotechnology

Published: November 20, 2025

Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers.

Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 10, 2025

Surgical outcomes using 3-dimensional image simulation for segmentectomy planning in patients with stage IA1-2 non-small cell lung cancer.

Surgical outcomes using 3-dimensional image simulation for segmentectomy planning in patients with stage IA1-2 non-small cell lung cancer.

Journal: The Journal of thoracic and cardiovascular surgery

Published: September 25, 2025

Out of the ivory tower: transitioning breathomics to clinical care.

Out of the ivory tower: transitioning breathomics to clinical care.

Journal: ERJ open research

Published: September 11, 2025

Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non-small cell lung cancer.

Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non-small cell lung cancer.

Journal: JTCVS open

Published: July 30, 2025

Editorial Expression of Concern to: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.

Editorial Expression of Concern to: TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.

Journal: Cell death & disease

Published: July 02, 2025

Should minimally invasive surgery be the standard approach for early-stage thymoma? A 20-year experience.

Should minimally invasive surgery be the standard approach for early-stage thymoma? A 20-year experience.

Journal: JTCVS techniques

Published: June 12, 2025

Commentary: Cum grano salis.

Commentary: Cum grano salis.

Journal: The Journal of thoracic and cardiovascular surgery

Published: June 10, 2025

Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non-small cell lung cancer.

Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non-small cell lung cancer.

Journal: The Journal of thoracic and cardiovascular surgery

Published: May 02, 2025

Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancers.

Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancers.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 01, 2025

Showing 1-12 of 350

Last Updated: 09/26/2026